DNAlite Therapeutics
San Francisco, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
MA
Mubhij AhmadExecutive Officer, Director
DC
David Cain RabukaDirector
TP
Timothy Paul DayDirector
AC
Andrew Cain McClaryDirector
DC
Drew Cain LanzaDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$5.6MraisedApr 2022 · 18 investors · BiotechnologyRule 506(b)
Officers, directors & promoters on the filing
- Mubhij AhmadExecutive Officer, Director
- David Cain RabukaDirector
- Timothy Paul DayDirector
- Andrew Cain McClaryDirector
- Drew Cain LanzaDirector
- Offering amount
- $8.9M
- Amount sold
- $5.6M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.